02367 GIANT BIOGENE
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 11.27X | Oper Margin | 42.4% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 34.7% |
| Total Debt/Equity | 0.1% | Return on Equity | 19.3% |
| Price/Book | 2.75X | Return on Assets | 17.7% |
| (HKD 28.340) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 2,131.40 | 2,193.31 | 1,600.12 | 780.35 | 989.25 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -2.8 | +37.1 | +105.1 | -21.1 | +0.9 |
| Earnings Per Share (HKD) | 2.036 | 2.234 | 1.639 | 1.11 | 1.015 |
| Earnings Per Share Growth (%) | -8.8 | +36.3 | +47.7 | +9.4 | +3.5 |
| Dividend Per Share (HKD) | 1.347 | 1.306 | 0.970 | No dividend | No dividend |
| P/E* (X) | 13.92 | 12.69 | 17.29 | 25.54 | 27.93 |
| Yield (%) | 4.75 | 4.61 | 3.42 | N/A | N/A |
| Dividend Share (%) | 66.16 | 58.46 | 59.18 | N/A | N/A |
| Book NAV (HKD) | 10.302 | 7.352 | 4.832 | 3.193 | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 5,519 | 5,539 | -0.4 | 3,524 |
| Operating Result | 2,341 | 2,461 | -4.9 | 1,745 |
| Associates | 9.495 | -3.601 | -363.7 | 0 |
| Profit Before Taxation | 2,350 | 2,458 | -4.4 | 1,745 |
| Taxation | 435.642 | 396.027 | +10.0 | 296.887 |
| Profit /( Loss) After Taxation | 1,915 | 2,062 | -7.1 | 1,448 |
| Minority Interests | -0.174 | -0.62 | -71.9 | -3.551 |
| Net Profit | 1,915 | 2,062 | -7.1 | 1,452 |
| Earnings Per Share () | 2.0363 | 2.2337 | -8.8 | 1.6390 |
| Dividend Per Share () | 1.3473 | 1.3059 | +3.2 | 0.9700 |
| Announcement Date | 2026-03-19 | 2025-03-26 | NA | 2024-03-25 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
